PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Microbiology and Immunology, College of Medicine, Seoul National University, Seoul, South Korea.\', \'Department of Biomedical Sciences, College of Medicine, Seoul National University, Seoul, South Korea.\', \'Liver Research Institute, College of Medicine, Seoul National University, Seoul, South Korea.\', \'Cancer Research Institute, College of Medicine, Seoul National University, Seoul, South Korea.\', \'Seoul National University Medical Research Center (SNUMRC), Seoul, South Korea.\', \'BK21 FOUR Biomedical Science Project, Seoul National University College of Medicine, Seoul, South Korea.\', \'Interdisciplinary Program in Cancer Biology, College of Medicine, Seoul National University, Seoul, South Korea.\', \'Wide River Institute of Immunology, Seoul National University, Hongcheon, South Korea.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.3389/fimmu.2021.712274
?:hasPublicationType
?:journal
  • Frontiers in immunology
is ?:pmid of
?:pmid
?:pmid
  • 34512635
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 2.803
?:rankingScore_hIndex
  • 69
is ?:relation_isRelatedTo_publication of
?:title
  • Recombinant Mycobacterium paragordonae Expressing SARS-CoV-2 Receptor-Binding Domain as a Vaccine Candidate Against SARS-CoV-2 Infections.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/34512635>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/34512635>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all